fsockopen(): unable to connect to ssl://query.yahooapis.com:443 (php_network_getaddresses: getaddrinfo failed: Name or service not known)




Israeli pride.  An innovative development with regards to babies' twisted feet. Children orthopedics is evolving with no need for casts or surgery.

UNFO MED Company was introduced this week during the thirty-third Orthopedics Conference held in Tel-Aviv. The company was previously titled one of Israel's promising companies in the Med in Israel Conference.  


What are the various ways of treating Metatarsus Adductus? Introducing a unique, easy-to- use solution, developed and manufactured in Israel, which solves the problem perfectly. 

Metatarsus Adductus is common amongst babies and is usually caused by the position of the baby in the womb. The baby's feet look like two halves moon bending towards one another. Up until today there has been no effective solution to this problem. The common treatment is the use of a special splint or casting of the foot till the baby turns 9 months old.


The cast is changed once a fortnight. The casts are outdated and were originally designated for a graver problem called Clubfoot. Usually the cast or splint is used till the baby starts walking. This obsolete and awkward treatment leads many families and doctors to avoid treatment due to the cumbersome process of changing the casts once a fortnight which is performed by a specialist doctor at a hospital or qualified stuff at a special ward. This tiresome process also requires preparation prior to the hospital visit. The process lasts for weeks and weeks and also involves dealing with hygienic issues related to the baby's stool and urine. When plastic casts are used the changing of casts is done by sawing which might cause injuries to the baby's feet.


In other cases, doctors recommend physiotherapy sessions at home, hoping to achieve some improvement. In such cases the responsibility falls on the parents rather than on the doctor. In the worst case scenarios, parents are sent home, being told that "there is no need for treatment, it will improve by itself". Indeed, sometimes the problem is solved without treatment, but in most cases it doesn't. One can never know in which case the problem will resolve itself and in which case the baby will continue to suffer from the problem and its side-effects in the future.


We are proud to introduce: a new, easy-to-use and effective solution to Metatarsus Adductus, made in Israel.

A one-of-a-kind biomechanical shoe which completely solves the problem. It is light, simple and elegant and has a unique feature – the shoe is worn below the ankle.

UNFO MED Ltd. which developed the footwear is an ISO 13485-certified orthopedic company.

The company was founded by Dr. Izak Daizade, a specialist in the field of orthopedic surgery with over 35 years of experience in the field. UNFO MED is the manufacturer of the revolutionary orthopedic system for newborn feet. The system is based on the expertise of Dr. Daizada in pediatric surgery. Dr. Daizade developed a treatment for Metatarsus Adductus and Clubfoot in newborns and is nowadays promoting this revolutionary treatment.



According to the company's owners there is no longer a reason to make do with answers such as "it will be fine" or "perhaps the problem will go away with time". You no longer have to go through the exhausting archaic treatments or complicated surgeries. The most important thing is to identify the problem at an early stage and start treating it with UNFO Foot Brace, preferably before the child is 6 months old. At a later stage it is much more difficult and complicated to treat the problem and it might even be impossible to do so.


What could happen if the child is not treated at all?   

According to Dr. Daizade it might cause future side effects which are usually reflected in footwear fitting, frequent wear and tear of shoes, calluses, pains, toes deformation and other orthopedic and aesthetic problems. It is easier to deal with the problem when the babies are younger and their skeleton is softer. You don't need to take the risk and see what the future holds.

Dr. Daizade adds that he is very proud that Israeli children are the first to enjoy this innovative treatment.


For further information :

Tel: 03-5010383

Address: 52 Weizmann Street, Holon


Photos provided by UNFO MED





"Through KKL-JNF, the Elkeles family continues to be a partner in the shaping of Israel's destiny, and once a trail is blazed, many people can walk on it."
KKL-JNF awarded the 2013 Samuel and Paula Elkeles Outstanding Scientist in Medicine Prize to Dr. Orly Elpeleg, the Head of the Department of Genetic and Metabolic diseases at Hadassah, at a moving ceremony at Hadassah Hospital in Jerusalem on Tuesday November 19. KKL-JNF World Chairman Efi Stenzler reaffirmed the organization's commitment to continue awarding this important prize in the future.

L-R: Barbara Goldstein, Harry Elyashiv, Prof. Orly Elpeleg, Efi Stenzler & Dr. Avigdor Kaplan. 
Photo: Tania Susskind

"I would like to congratulate Professor Orly Elpeleg, who was chosen as this year's recipient of the Samuel and Paula Elkeles Outstanding Scientist in Medicine Prize. Israel's entire populace and all of humanity benefits from your success," said KKL-JNF World ChairmanEfi Stenzler at the Elkeles prize giving ceremony at Hadassah Hospital in Jerusalem. The ceremony, which took place on Tuesday, November 19 was attended by Hadassah personnel, family, friends and distinguished guests, including Ms. Barbara Goldstein, a member of the KKL-JNF Directorate and the Deputy Executive Officer of Hadassah's office in Israel.

KKL-JNF World Chairman Efi Stenzler. Photo: Tania Susskind

"Israel is at the forefront of technological and scientific endeavor," Mr. Stenzler continued, "and many of KKL-JNF's achievements in various fields are based on innovative research, from desert afforestation, to recycling 87% of the country's wastewater for agriculture usage, and much more. Through KKL-JNF, the Elkeles family continues to be a partner in the shaping of Israel's destiny, and once a trail is blazed, many people can walk on it." 

Dr. Ludwig Elkeles established the foundation in memory of his parents, the late Samuel and Paula Elkeles. The family had its origins in Berlin, but Ludwig and his parents left Germany for England in 1936 as the Nazi regime rose to power. After the Second World War, Elkeles, an economist by profession, returned to Germany, and throughout the years maintained a strong connection with Israel. Towards the end of his life, he expressed a wish to donate his personal fortune to an enterprise that would benefit the Israeli public. He chose KKL-JNF as the partner for his donation, which was used to fund numerous projects, including a recreation area and playground in the Jerusalem Forest, a scenic lookout at Kadesh Barnea in the Negev, and the Mitzpe Gvulot site in the Negev. Elkeles also wished his estate to be used for the creation of a special foundation in memory of his parents, which would present an annual award for medical research.

Prof. Orly Elpeleg with Dr. Avigdor Kaplan. Photo: Tania Susskind

Towards the conclusion of the ceremony, Mr. Stenzler surprised the audience when he returned to the podium to make an exciting announcement: "The Elkeles prize has been awarded to outstanding scientists for the past twenty-five years, but at the present time, there are insufficient funds to continue this tradition. However, in recognition of the importance of encouraging medical research, KKL-JNF has decided to commit itself to continue awarding the prize in the future," Stenzler declared, to loud applause from the audience. 

This year's prize recipient is Dr. Orly Elpeleg, head of the Department of Genetic and Metabolic diseases at Hadassah. Over the past decade, she has focused on gene discovery in a large number of rare disorders, and has published reports on 30 novel disease-associated genes. She has participated in extensive national and international collaborations and has coauthored over 140 peer-reviewed articles. 

Dr. Avigdor Kaplan, Director General of Hadassah Medical Organization, said that seeing children suffer is what motivated Professor Elpeleg to try and discover the reason for their diseases. "Many of us saw the movie that described how a small girl who couldn't walk was eventually able to dance thanks to Professor Elpeleg's research. The entire Hadassah family is very proud of her." 

Professor Yaakov Naparstek, Head of the Division of Medicine at Hadassah, thanked KKL-JNF and the Elkeles family for awarding the prize. "It is my firm belief that biomedical research should be conducted at medical centers like Hadassah, where it is possible to go from the research bench to the patient's bedside, and vice-versa. There are those who think that doctors who are also research scientists are a dying breed, but at Hadassah Hospital, we feel that this is critical to the future of medical research. Dr. Elpeleg's success proves just how important this is."

Hadassah Elkeles, neice of Samuel Elkeles Z"L. Photo: Tania Susskind

Hadassah Elkeles, Samuel Elkeles' niece, who represented the family, said that this year's ceremony was especially moving for her, because the recipient of the prize is a woman. She spoke about her family's history, and mentioned that her family had donated to KKL-JNF during the 1920s, when they lived in Europe. "I even showed the receipts to Mr. Stenzler. My uncle, who had originally intended to study medicine, was a great supporter of Israel and KKL-JNF. In this family tradition, my father's last words were, 'Next year in the Land of Israel.'" 

Professor Orly Elpeleg was very moved to receive the prize. "Every successful research project needs partners, so I would describe this as our rather than as my research. In the 1980s, there were three categories of children's diseases – infectious diseases, cancerous diseases and all the rest, which were largely ignored in the textbooks, so I decided to research them. We were looking for disease-infected genes, which was sort of like looking for a specific carp in the ocean. To date, we have discovered 30 such genes, findings that have enabled breakthroughs in treating various children's diseases. 

"There is no research without belief – belief in your own personal ability, belief in your partners, and belief in your goal. I want to thank KKL-JNF and the Elkeles family, not for choosing me for the prize, but for highlighting our research. It is an affirmation of us and of our work." 

Dr. Osnat Levtziyon-Korach, Director of the Hadassah University Hospital on Mount Scopus, presented the committee's reasons for this year's choice, and the ceremony, which was graciously facilitated by KKL-JNF's Rivka Rey, concluded with the presentation of the prize and a KKL-JNF certificate of appreciation to Professor Elpeleg.




Italian vegetable vendors have signed an agreement to grow potatoes in the Negev during the winter, with the aim of retaining a supply of fresh produce when the Italian cold does not enable growing


The European seed company, Germicopa, sent diploid potato seeds to Negev farmers, for them to grow during the winter, when whether conditions in Italy are not conducive for growing.  This joint venture is aimed at avoiding any severance of the marketing sequence, enabling Italy’s regions to enjoy fresh produce in the winter as well.


According to Abraham Rothstein, CEO of "Tozza" (representing Germicopa), this is a preliminary export of the species from Israel to Italy. The Italian vendors discovered the combination of good winter weather in the Negev and the quality of southern farming products.


The first transaction entails the export of 450 tons derived of the Negev fields.  In light of the demand for this species in Italy, measures will be taken to increase the scope of marketing next winter.


The diploid seeds were brought to Israel after joint planning by the Italian distributor and Negev farmers in Israel.  The diploid has a unique flavor and color that is loved by Italian consumers, especially in Sicily.  The species produces high yields and is suitable for mashed potatoes, gnocchi, filling pocket pastries, knishes and baking.


The Germicopa seeds are advanced hybrid seeds created under full growth control in isolated areas of the French Brittany region.


Rothstein adds that the Israeli market is very important to the Europeans, seeing that we serve as their vegetable barn during the winter, when the ground on the continent is frozen, preventing vegetable growth in open areas.  In the past, Europeans made do with vegetables that were stored since the summer or obtained through limited import, but as the standard of living improved in Russia and Eastern Europe, so did the demand for vegetables in the winter and spring.






SanDisk Ventures officially introduced itself on Sunday and called for opportunities to invest in Israeli companies at an investment event in the old city of Jaffa and Tel Aviv coast.


In the event, that was held as a conference, leading multinational corporates, as well as venture capitals and startups from the Israeli ecosystem, discussed the future of storage and the innovations taking place in the global enterprise cloud and mobile flash storage industry.


Among guests there were Drew Henry, SanDisk Senior Vice President and General Manager of the Mobile and Connected Solutions; Rene Hartner, SanDisk Senior Director, Corporate Strategy & Business Development,  David Flynn, PrimaryData CEO and ex founder and CEO of Fusion-IO; Riccardo Badalone, Diablo Technologies CEO; Bryan Bogensberger, Inktank CEO; Emil Alon, Pebbles Interfaces CEO and Oren Boiman of Magisto, CEO.


"We see Israel, as a leading hub of storage solution companies, technology and innovation," said Amir Fridman, SanDisk Director of Corporate Strategy & Business Development.


"SanDisk will be investing over $75 million dollars in select early- to mid-stage companies that demonstrate innovation across the spectrum of flash storage, from companies with solutions that enhance enterprise storage applications to companies that develop consumer products. By collaborating with SanDisk, these companies gain access to a broad product portfolio from a recognized leader in flash, world-class technical expertise, customer introductions and an expanded channel for their products and services".


In the last year, SanDisk announced five investments, 3 three in the US and 2 two in Israel, Pebbles Interfaces and Magisto.


Photo  Ifat Golan. from right: Drew Henry and Amir Fridman.




Creating Water for Israel at WATEC 2013


KKL-JNF at WATEC: The International Water Exhibition


WATEC Israel is an international professional exhibition of the latest water and environmental quality technologies, such as desalination, advanced irrigation systems, water shortage solutions, leakage control, water monitoring, purification, water saving devices and much, much more.
The WATEC  exhibition will be held at the Exhibition Grounds in Tel Aviv
Admission is free! 

On Wednesday, 23rd October, KKL-JNF will conduct a tour of the biofilter, an exciting water recycling innovation in Kfar Saba. 

This year, the exhibition will focus on the different technologies that can help to more effectively utilize natural resources, including water. 

The public is invited to visit the booth of KKL-JNF, which is participating in the exhibition for the fourth time, and to learn about the extensive activities of KKL-JNF in Israel and around the world. The booth will focus on the field of water, under the heading "Creating Water." 

October 23: Tour to Kfar Saba biofilter with JNF

KKL-JNF offers visitors the opportunity to learn about the biofilter, a unique engineering system that captures and treats urban runoff and contaminated groundwater. 

Meeting time: 11:00 

Meeting Point: KKL-JNF booth (Hall 10 , booth 55) 

Tour Guide: Dr. Yaron Singer, key initiator of the biofilter. 

Approximate schedule:

 - Lecture JNF booth at WATEC 

11:30 - traveling to Kfar Saba 

13:00 - Back to the exhibition grounds. 

The tour includes a ride to biofilter and back, light snacks and drinks. Participation in the tour is free. 

For details and registration: Patricia Ben Amo - Tel. 03-5261160 | 050-5220257 | //www.kkl.org.il/eng/This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank" style="margin:0px;padding:0px;border:0px;outline:0px;cursor:pointer;color:rgb(84, 84, 84);text-decoration:underline;text-align:center;font-size:12px;font-family:Arial">Email
You can also register for the tour at the KKL-JNF booth. 

The biofilter in brief:
The water treated by the system is stored in an underground aquifier.
You can pump the water from any point along the aquifer and utilized it for a variety of uses.
The system is currently beign tested in Kfar Saba and its implementation will allow the distribution of large quantities of clean water in Israel's larger cities.